Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Prospective Catalystem CT-RSA

NCT: NCT07698717 · NOT_YET_RECRUITING

NCT IDNCT07698717
StatusNOT_YET_RECRUITING
Start Date2026-08-01
Completion2028-12-31
SponsorCanadian Radiostereometric Analysis Network (OTHER)
First posted
Last updated

Brief Summary

Multi-Centre Study in patients undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The primary objective is to establish the mean inferior stem migration (subsidence) of the CATALYSTEM™ stem using CT-RSA over the first two postoperative years.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑